Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-07-30 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE PERREUX-SUR-MARNE (94170), Val-de-Marne
PHARMACIE THIBAULT-LAURENT : revenue, balance sheet and financial ratios
PHARMACIE THIBAULT-LAURENT is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE PERREUX-SUR-MARNE (94170),
this company of category PME
shows in 2022 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE THIBAULT-LAURENT (SIREN 812932101)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
1 803 380 €
N/C
N/C
1 380 247 €
1 456 915 €
2 045 788 €
Net income
944 €
70 834 €
137 621 €
70 525 €
41 882 €
61 421 €
94 186 €
25 128 €
EBITDA
N/C
N/C
190 724 €
N/C
N/C
95 772 €
141 666 €
162 168 €
Net margin
N/C
N/C
7.6%
N/C
N/C
4.5%
6.5%
1.2%
Revenue and income statement
In 2024, PHARMACIE THIBAULT-LAURENT generates positive net income of 944 €. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 25 k€ -> 944 €.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
944 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 118%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
117.518%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
36.722%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
1383.682
529.969
401.844
323.965
227.892
140.307
112.895
117.518
Financial autonomy
5.243
12.585
16.382
19.57
25.112
33.625
37.381
36.722
Repayment capacity
31.152
7.311
9.508
None
None
3.639
None
None
Cash flow / Revenue
1.196%
6.633%
4.973%
None%
None%
7.67%
None%
None%
Sector positioning
Debt ratio
117.522024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE THIBAULT-LAURENT (117.52) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
36.72%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE THIBAULT-LAURENT (36.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.64 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE THIBAULT-LAURENT (3.64) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 119.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
125.97
141.302
136.897
137.829
46.025
162.375
147.307
119.515
Interest coverage
9.96
6.825
9.162
None
None
3.421
None
None
Sector positioning
Liquidity ratio
119.522024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch-10 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE THIBAULT-LAURENT (119.52) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
3.42x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE THIBAULT-LAURENT (3.4x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE THIBAULT-LAURENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
181 993 €
181 925 €
235 622 €
0 €
0 €
168 526 €
0 €
0 €
Inventory turnover (days)
26
43
45
0
0
39
0
0
Customer payment term (days)
4
10
11
0
0
5
0
0
Supplier payment term (days)
41
51
52
0
0
33
0
0
Positioning of PHARMACIE THIBAULT-LAURENT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE THIBAULT-LAURENT is estimated at
13 178 €
(range 9 177€ - 19 716€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
9k€13k€19k€
13 178 €Range: 9 177€ - 19 716€
NAF 5 année 2024
Valuation method used
Net Income Multiple
944 €
×
14.0x
=13 179 €
Range: 9 178€ - 19 716€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE THIBAULT-LAURENT with other companies in the same sector:
Frequently asked questions about PHARMACIE THIBAULT-LAURENT
What is the revenue of PHARMACIE THIBAULT-LAURENT ?
The revenue of PHARMACIE THIBAULT-LAURENT in 2022 is 1.8 M€.
Is PHARMACIE THIBAULT-LAURENT profitable?
Yes, PHARMACIE THIBAULT-LAURENT generated a net profit of 944€ in 2024.
Where is the headquarters of PHARMACIE THIBAULT-LAURENT ?
The headquarters of PHARMACIE THIBAULT-LAURENT is located in LE PERREUX-SUR-MARNE (94170), in the department Val-de-Marne.
Where to find the tax return of PHARMACIE THIBAULT-LAURENT ?
The tax return of PHARMACIE THIBAULT-LAURENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE THIBAULT-LAURENT operate?
PHARMACIE THIBAULT-LAURENT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart